Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether droxidopa is effective in treating symptoms of
neurogenic orthostatic hypotension in patients with Primary Autonomic Failure (Pure Autonomic
Failure, Multiple System Atrophy, Parkinson's Disease), Non-diabetic neuropathy, or Beta
Hydroxylase deficiency.